ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.320,96
0,33%
S&P 500
5.631,22
0,28%
US Dollar vs BRL
5,4489
0,01%
Bitcoin
63.782,87
-1,65%
Brent Oil
83,185
-1,37%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Avid Bioservices Inc (CDMOP)

  7. Avid Bioservices Inc (CDMOP) Notícias

CDMOP

Avid Bioservices (CDMOP)

Avid Bioservices Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP
DataHoraFonteTítuloCódigoCompanhia
01/07/202109:05GlobeNewswire Inc.Avid Bioservices Announces Appointment of Esther M. Alegria, Ph.D., to Board of DirectorsNASDAQ:CDMOPAvid Bioservices Inc
29/06/202117:45Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CDMOPAvid Bioservices Inc
29/06/202117:23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDMOPAvid Bioservices Inc
29/06/202117:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
22/06/202117:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results For Quarter and Fiscal Year Ended April 30, 2021 After Market Close on June 29, ...NASDAQ:CDMOPAvid Bioservices Inc
25/05/202109:05GlobeNewswire Inc.Avid Bioservices to Serve as Commercial Manufacturer for ADC Therapeutics’ ZYNLONTA™ (Loncastuximab Tesirine-Lpyl)NASDAQ:CDMOPAvid Bioservices Inc
07/05/202120:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
15/04/202117:05GlobeNewswire Inc.Avid Bioservices Announces Completion of Redemption of Series E Convertible Preferred StockNASDAQ:CDMOPAvid Bioservices Inc
12/04/202117:39Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CDMOPAvid Bioservices Inc
17/03/202109:05GlobeNewswire Inc.Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor ForumNASDAQ:CDMOPAvid Bioservices Inc
10/03/202102:20GlobeNewswire Inc.Avid Bioservices, Inc. Announces Pricing of $125 Million Offering of Exchangeable Senior NotesNASDAQ:CDMOPAvid Bioservices Inc
08/03/202119:01GlobeNewswire Inc.Avid Bioservices, Inc. Announces Proposed $125 Million Offering of Exchangeable Senior NotesNASDAQ:CDMOPAvid Bioservices Inc
08/03/202118:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2021 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
03/03/202118:05GlobeNewswire Inc.Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred StockNASDAQ:CDMOPAvid Bioservices Inc
01/03/202118:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2021 After Market Close on March 8, 2021NASDAQ:CDMOPAvid Bioservices Inc
22/02/202110:05GlobeNewswire Inc.Avid Bioservices Begins Phase 2 of its Myford Manufacturing Capacity Expansion PlanNASDAQ:CDMOPAvid Bioservices Inc
16/02/202117:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CDMOPAvid Bioservices Inc
03/02/202109:00GlobeNewswire Inc.Humanigen and Avid Bioservices Enter into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Suppo...NASDAQ:CDMOPAvid Bioservices Inc
03/02/202109:00Business WireHumanigen & Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support...NASDAQ:CDMOPAvid Bioservices Inc
14/12/202018:05GlobeNewswire Inc.Avid Bioservices Announces Closing of Public Offering of Common StockNASDAQ:CDMOPAvid Bioservices Inc
11/12/202019:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CDMOPAvid Bioservices Inc
10/12/202011:00GlobeNewswire Inc.Avid Bioservices Announces Pricing of Public Offering of Common StockNASDAQ:CDMOPAvid Bioservices Inc
09/12/202018:45GlobeNewswire Inc.Avid Bioservices Announces Proposed Public Offering of Common StockNASDAQ:CDMOPAvid Bioservices Inc
07/12/202018:05GlobeNewswire Inc.Avid Bioservices Announces Appointment of Jeanne Thoma to Board of DirectorsNASDAQ:CDMOPAvid Bioservices Inc
02/12/202018:37Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CDMOPAvid Bioservices Inc
02/12/202018:05GlobeNewswire Inc.Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2021 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
24/11/202018:05GlobeNewswire Inc.Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2021 After Market Close on December 2, 2020NASDAQ:CDMOPAvid Bioservices Inc
15/09/202017:36Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CDMOPAvid Bioservices Inc
15/09/202017:05GlobeNewswire Inc.Avid Bioservices Announces Move to Virtual-Only Annual Meeting of Stockholders on October 20, 2020NASDAQ:CDMOPAvid Bioservices Inc
10/09/202009:05GlobeNewswire Inc.Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare ConferenceNASDAQ:CDMOPAvid Bioservices Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
TELB4
TELEBRAS PN
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
AZEV4
AZEVEDO PN
BOV
AERI3
Aeris Industria E Comerc... ON
BOV
AMER3
Americanas ON
BOV
GFSA3
GAFISA ON
BOV
INBR32
Inter &
BOV
HBOR3
HELBOR ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados